News

Targeted Drug Delivery in Rheumatoid Arthritis: Leveraging Collagen Hybridizing Peptides for Enhanced Therapeutic Efficacy

     Histological staining of mouse tibia-talus joints showing healthier articular cartilage due to iFab-CHP treatment compared PBS placebo.      Rheumatoid arthritis (RA) is a chronic autoimmune disease which leads to the breakdown of the cartilage in the synovial joints. Current treatment strategies with tumor necrosis factor-alpha (TNFa)  targeting neutralizing antibodies effectively reduce...
View Details

Using Collagen Hybridizing Peptides to Improve IPF Diagnosis and Imaging

     Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease marked by rapid progressive lung failure due to an accumulation of fibrotic collagen tissue. Due to the rapid onset of the disease, accurate and effective diagnostic tools are crucial for improving patient outcomes. Additionally, monitoring patient response to treatment should be minimally invasive...
View Details

Collagen Hybridizing Peptides Conjugated to Water-Soluble Copolymers for Targeting Intratibial Osteosarcoma

Discover innovative strategies for treating osteosarcoma (OS) with localized drug delivery using Collagen Hybridizing Peptides (CHPs). OS, a malignant bone cancer, often requires surgery and chemotherapy, but these treatments are plagued by systemic side effects. This research highlights the potential of CHPs to selectively target tumors by binding to damaged collagen in bone tissue.
View Details